NanoTemper's Strategic Advancements in Biopharma Through Envue Acquisition and Dianthus α Launch NanoTemper has enhanced its biopharma discovery portfolio by acquiring Envue Technologies and launching the innovative Dianthus α application, driving advancements in drug discovery.

NanoTemper's Strategic Advancements in Biopharma Through Envue Acquisition and Dianthus α Launch #Germany #Munich #NanoTemper #Dianthus_α #Envue_Technologies